欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
ES/H/0469/002
药品名称
Rizatriptano Pharmathen
活性成分
rizatriptan benzoate 10.0 mg
剂型
Tablet
上市许可持有人
Pharmathen SA
参考成员国 - 产品名称
Spain (ES)
互认成员国 - 产品名称
许可日期
2012/10/12
最近更新日期
2024/06/24
药物ATC编码
N02CC04 rizatriptan
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PubAR
|
54092_54093_54094_54095_20141105_PAR_IRS
Date of last change:2024/09/06
Final Product Information
|
common_outer_d210
Date of last change:2024/09/06
Final Product Information
|
common_outer_d210_odt
Date of last change:2024/09/06
Final Product Information
|
common_pl_d210
Date of last change:2024/09/06
Final Product Information
|
common_pl_d210_odt
Date of last change:2024/09/06
Final Product Information
|
common_spc_d210
Date of last change:2024/09/06
Final Product Information
|
common_spc_d210_odt
Date of last change:2024/09/06
Final SPC
|
Ccommon SPC
Date of last change:2024/09/06
Final PL
|
common PL
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase